Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|April 28, 2012
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulationYong Hannah Wen, Alice Ho, Sujata Patil, et al.
Nature Communications|July 12, 2017
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic targetPeter J Cook, Rozario Thomas, Ram Kannan, et al.
Cancer Research|November 4, 2010
Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumorsFreddy E Escorcia, Erik Henke, Michael R McDevitt, et al.
Nature Communications|March 14, 2018
Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic targetPeter J Cook, Rozario Thomas, Ram Kannan, et al.
The American Journal of Pathology|September 9, 2015
Id1 expression in endothelial cells of the colon is required for normal response to injuryNing Zhang, Kotha Subbaramaiah, Rhonda K Yantiss, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2003
Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumorsPaola de Candia, David B Solit, Dilip Giri, et al.
Nature Biotechnology|January 8, 2008
Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivoErik Henke, Jonathan Perk, Jelena Vider, et al.
Neuro-Oncology|March 30, 2016
Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastomaPeter J Cook, Rozario Thomas, Philip J Kingsley, et al.
Pageof 8